【24h】

Treatment of acne vulgaris.

机译:寻常痤疮的治疗。

获取原文
获取原文并翻译 | 示例
       

摘要

CONTEXT: Management of acne vulgaris by nondermatologists is increasing. Current understanding of the different presentations of acne allows for individualized treatments and improved outcomes. OBJECTIVE: To review the best evidence available for individualized treatment of acne. DATA SOURCES: Search of MEDLINE, EMBASE, and the Cochrane database to search for all English-language articles on acne treatment from 1966 to 2004. STUDY SELECTION: Well-designed randomized controlled trials, meta-analyses, and other systematic reviews are the focus of this article. DATA EXTRACTION: Acne literature is characterized by a lack of standardization with respect to outcome measures and methods used to grade disease severity. DATA SYNTHESIS: Main outcome measures of 29 randomized double-blind trials that were evaluated included reductions in inflammatory, noninflammatory, and total acne lesion counts. Topical retinoids reduce the number of comedones and inflammatory lesions in the range of 40% to 70%. These agents are the mainstay of therapy in patients with comedones only. Other agents, including topical antimicrobials, oral antibiotics, hormonal therapy (in women), and isotretinoin all yield high response rates. Patients with mild to moderate severity inflammatory acne with papules and pustules should be treated with topical antibiotics combined with retinoids. Oral antibiotics are first-line therapy in patients with moderate to severe inflammatory acne while oral isotretinoin is indicated for severe nodular acne, treatment failures, scarring, frequent relapses, or in cases of severe psychological distress. Long-term topical or oral antibiotic therapy should be avoided when feasible to minimize occurrence of bacterial resistance. Isotretinoin is a powerful teratogen mandating strict precautions for use among women of childbearing age. CONCLUSIONS: Acne responses to treatment vary considerably. Frequently more than 1 treatment modality is used concomitantly. Best results are seen when treatments are individualized on the basis of clinical presentation.
机译:背景:非皮肤科医生对寻常痤疮的管理正在增加。当前对痤疮的不同表现形式的理解允许个体化治疗和改善结果。目的:回顾可用于痤疮个体化治疗的最佳证据。数据来源:搜索MEDLINE,EMBASE和Cochrane数据库以搜索1966年至2004年间所有关于痤疮治疗的英语文章。研究选择:精心设计的随机对照试验,荟萃分析和其他系统评价是重点本文的内容。数据提取:痤疮文献的特点是缺乏用于评估疾病严重程度的预后指标和方法的标准化。数据综合:评估的29项随机双盲试验的主要结局指标包括炎性,非炎性和总痤疮病变数量减少。局部类维生素A减少粉刺和炎性病变的数量在40%至70%的范围内。这些药物仅是粉刺患者的主要治疗药物。其他药物,包括局部抗菌药,口服抗生素,激素治疗(女性)和异维A酸,都可产生高应答率。轻度至中度炎症性痤疮伴丘疹和脓疱的患者应使用局部抗生素与类维生素A联合治疗。口服抗生素是中度至重度炎性痤疮的一线治疗,而口服异维A酸则适用于严重的结节性痤疮,治疗失败,结疤,频繁复发或严重的心理困扰。在可行的情况下,应避免长期的局部或口服抗生素治疗,以最大程度地减少细菌耐药性的发生。异维A酸是一种有力的致畸剂,必须对在育龄妇女中使用时采取严格的预防措施。结论:痤疮对治疗的反应差异很大。通常会同时使用一种以上的治疗方式。当根据临床表现个体化治疗时,可以看到最佳结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号